申请人:NOVARTIS AG
公开号:WO2005123732A1
公开(公告)日:2005-12-29
The present invention relates to 1-aza-bicycloalkyl derivatives of Formula (I); wherein the substituents are as defined in the specification, to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them. Formula (I), wherein A represents O or N(R1); Y represents a group of formula, or wherein the left bond is attached to the A group and the right bond is attached to the R group; R represents a substituted or unsubstituted C5- C10aryl, substituted or unsubstituted hetero-C5-C10aryl, a group N(R1)(R4), or a group N(R2)(CHP3R4); R represent a hydrogen, C1-C4alkyl, or CF3; R2 represents hydrogen, C1-C4alkyl, or CF3; R3 represents hydrogen, C1-C4alkyl, or CF3; R4 represents a substituted or unsubstituted C5-C10 aryl or a substituted or unsubstituted C5-C10heteroaryl; in free base or acid addition salt form.
本发明涉及式(I)的1-aza-bicycloalkyl衍生物;其中取代基如说明书所定义,以及它们的制备方法,它们作为药物的用途以及包含它们的药物组合物。式(I)中,A代表O或N(R1);Y代表式的一个群或其中左键连接到A群,右键连接到R群;R代表取代或未取代的C5-C10芳基,取代或未取代的杂环C5-C10芳基,一个群N(R1)(R4),或一个群N(R2)(CHP3R4);R代表氢、C1-C4烷基或CF3;R2代表氢、C1-C4烷基或CF3;R3代表氢、C1-C4烷基或CF3;R4代表取代或未取代的C5-C10芳基或取代或未取代的C5-C10杂环芳基;以自由碱或酸盐形式存在。